
Dr. Hans Lafford
About Dr. Hans Lafford
Subspecialty
Nuclear Medicine
Education
Bachelor of Science (B.Sc. Honours, Neuroscience) – Dalhousie University
Masters in Health Administration (MHA) – Dalhousie University
Doctor of Medicine (MD) – Dalhousie University
Diagnostic Radiology Residency – Cumming School of Medicine, University of Calgary
Nuclear Medicine Residency – Temerty Faculty of Medicine, University of Toronto
Certifications
Licentiate if the Medical Council of Canada (LMCC)
Royal College of Physicians and Surgeons of Canada – Specialist in Diagnostic Radiology
Royal College of Physicians and Surgeons of Canada – Nuclear Medicine Physician
Certified Health Executive (CHE) – Canadian College of Health Leaders
Professional Organizations
Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) - Diagnostic Radiology
Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) – Nuclear Medicine
College of Physicians and Surgeons of Alberta (CPSA)
Canadian Association of Nuclear Medicine (CANM)
Society of Nuclear Medicine and Molecular Imaging (SNMMI)
European Association of Nuclear Medicine (EANM)
Canadian Association of Radiologists (CAR)
Canadian Medical Association (CMA)
Canadian College of Health Leaders (CCHL)
Research
Kloiber R, Lafford H, Koslowsky IL, Tchajkov I, Rabin HR. A practical approach to interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for postoperative spine infection. Skeletal Radiol. 2024 Apr;53(4):741-752. doi: 10.1007/s00256-023-04474-6. Epub 2023 Oct 23. PMID: 37867181.
Lafford HW, Stewart EE, Koslowsky IL, Rabin HR, Kloiber R. The routine clinical use of fluorodeoxyglucose PET/CT to confirm treatment response in pyogenic spine infection. Skeletal Radiol. 2024 Jan;53(1):161-170. doi: 10.1007/s00256-023-04393-6. Epub 2023 Jul 1. PMID: 37393203.
